Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P020003/S012

Torosa Saline Filled Testicular Prosthesis

Coloplast Corp. · Decision date Jul 21, 2026

FDA DECISIONP020003/S012

What did the FDA decide?

FDA records P020003/S012 as a supplement to PMA P020003, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 21, 2026.

FDA approval order statement

to increase the amount of manufacturing cleanroom space by converting existing space into a new cleanroom, along with installing a deionized water system and clean dry air system in the cleanroom
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Gastroenterology, Urology
Decision date
Jul 21, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P020003/S012
Regulatory pathway
PMA supplement
Product code
FAF
Decision code
OK30
Decision date
Jul 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, testicular.

Product code
FAF
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P020003/S012 received

    Application receipt date recorded by FDA.

  2. P020003/S012 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P020003. View FDA’s full supplement list.

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Coloplast Corp.

Headquarters
Not reported
Brand website
coloplast.com
FDA applicant address
1601 W. River Rd. N., Plymouth, MN, 55411

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records